C-reactive protein thresholds for discriminating active disease in psoriatic arthritis may be different in early versus established disease
Our results suggest the adoption of lower than standard CRP cut-off values for a better assessment of PsA in clinical practice. This seems to be more applicable in established than in recent-onset PsA.
Authors
- Marta Loredo (ORCID: https://orcid.org/0009-0005-8084-2068)
- Rubén Queiró (ORCID: https://orcid.org/0000-0002-8418-7145)
- Pablo González del Pozo (ORCID: https://orcid.org/0009-0000-4448-4690)
- Paula Alvarez (ORCID: https://orcid.org/0009-0000-0795-4307)
- Norma Calleja
Institutions
- Hospital Universitario Central de Asturias (ES)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2024-09-04
- DOI
- https://doi.org/10.55563/clinexprheumatol/8dazct
- Citations
- 3
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.41